For any questions on the voting procedures, you can contact the Investor Relations team by e-mail: [email protected].
PARIS, BOULDER (Colorado-United States), July 11, 2023 at 6:00 p.m. CEST – SpineGuard (FR0011464452 – ALSGD, eligible PEA-PME), an innovative company that designs, develops and markets medical devices intended to secure and simplify placement bone implants, announces its sales for the first half of 2023.
Pierre Jérôme, CEO and Co-founder of SpineGuard, said: “Our product sales in the second quarter are extremely contrasted between the United States and the rest of the world. The temporary decline in the United States reflects the low level of orders from our main US distributor, which is experiencing financial and governance difficulties independent of our activity. To overcome this, we have significantly expanded our American sales team with the recent hiring of four new employees. Our new DSG Connect and PediGuard Threaded products continue to be well received in the field and the two ongoing co-developments with Omnia Medical are progressing. In the rest of the world, very strong growth in PediGuard sales continues to be driven by Europe and Latin America. They reinforce the relevance and potential of our technology, including in the United States. »